ChiCTR2000038850.

Study name	'A randomized controlled clinical study of sound therapy combined with drug therapy for tinnitus'
Methods	RCT
Participants	n = 44 Inclusion criteria: 1) patients with tinnitus frequency between 125 Hz and 8000 Hz; 2) patients with chronic tinnitus (Otolaryngology ‐ Head and Neck Surgery 2014 tinnitus clinical guidelines: chronic tinnitus is defined as continuous tinnitus lasting more than 6 months at the time of examination); 3) patients without tinnitus treatment; 4) patients who did not take stimulants and ototoxic drugs; 5) patients who are willing to follow up Exclusion criteria: 1) pulsatile tinnitus; 2) patients with a history of auditory trauma; 3) patients with middle or inner ear diseases (such as otosclerosis, chronic suppurative otitis media or endolymphatic hydrops); 4) severe hearing asymmetry between ears, patients with post cochlear lesions, tinnitus induced by previous ear surgery and other diseases; 5) patients with head and neck discomfort or tinnitus caused by temporomandibular or cranial neck; 6) have used or are using other oral drugs to improve microcirculation within 3 months; 7) women who are pregnant or prepare for pregnancy within 12 months; 8) patients with severe chronic diseases not under control
Interventions	Oral administration of Ginkgo biloba extract tablets vs music combined with medication
Outcomes	Tinnitus Handicap Inventory, Zung Self‐Rating Anxiety Scale (SAS), electroencephalogram (EEG)
Starting date	1 December 2020
Contact information	Jianlong Wu
Notes	Status: recruiting

RCT: randomised controlled trial